OBESITAS 2026 concludes with focus on India’s rising obesity burden

The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges

Summer heat may strain liver health, say doctors on World Liver Day

Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures

GoodRx partners with Eli Lilly to expand access to new oral GLP-1 Foundayo & Zepbound KwikPen

GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access

AstraZeneca, Roche-backed study supports risk-based HF screening in diabetes

Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care

Eli Lilly trial shows combo therapy dramatically improves psoriatic arthritis, obesity outcomes

The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology

Zealand Pharma launches major US research hub in Cambridge, Massachusetts

The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities

Eli Lilly’s experimental drug Retatrutide shows major breakthrough in Type 2 diabetes trial

DrStore partners with TatvaCare to revolutionize diabetes & metabolic care in India

Zeus Hygia and Patch House Labs join forces to take nutraceuticals beyond the pill

The agreement will see the two companies jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats

Sun Pharma gets DCGI nod to launch generic Semaglutide injection for weight loss in India

Company to launch product after the expiry of semaglutide patent in India